Enoxacin
From Wikipedia, the free encyclopedia
 |
|
|---|---|
| Systematic (IUPAC) name | |
| 1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid | |
| Clinical data | |
| AHFS/Drugs.com | monograph |
| MedlinePlus | a601013 |
| Pregnancy cat. | ? |
| Legal status | ? |
| Routes | Oral |
| Identifiers | |
| CAS number | 74011-58-8  |
| ATC code | J01MA04 |
| PubChem | CID 3229 |
| DrugBank | APRD00947 |
| ChemSpider | 3116 |
| UNII | 325OGW249P |
| KEGG | D00310 |
| ChEBI | CHEBI:157175 |
| ChEMBL | CHEMBL826 |
| Chemical data | |
| Formula | C15H17FN4O3 |
| Mol. mass | 320.319 g/mol |
| SMILES | eMolecules & PubChem |
|
|
 (what is this?) (verify) |
|
Enoxacin (sold under the following trade names Almitil, Bactidan, Bactidron, Comprecin, Enoksetin, Enoxen, Enroxil, Enoxin, Enoxor, Flumark, Penetrex, Gyramid, Vinone) is an oral broad-spectrum fluoroquinolone antibacterial agent used in the treatment of urinary tract infections and gonorrhea. Insomnia is a common adverse effect.[1][2] It is no longer available in the United States.
[edit] References
- ^ Rafalsky, V.; Andreeva, I.; Rjabkova, E.; Rafalsky, Vladimir V (2006). Rafalsky, Vladimir V. ed. "Quinolones for uncomplicated acute cystitis in women". Cochrane Database Syst Rev 3: CD003597. doi:10.1002/14651858.CD003597.pub2. PMID 16856014.
- ^ Mogabgab, WJ. (Dec 1991). "Recent developments in the treatment of sexually transmitted diseases". Am J Med 91 (6A): 140S–144S. doi:10.1016/0002-9343(91)90327-T. PMID 1767802.
[edit] Additional reading
- Patel SS, Spencer CM (January 1996). "Enoxacin: a reappraisal of its clinical efficacy in the treatment of genitourinary tract infections". Drugs 51 (1): 137–60. PMID 8741236..
[edit] External links
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
This systemic antibacterial-related article is a stub. You can help Wikipedia by expanding it. |
